Publication | Closed Access

Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis

Antifungal AgentFungal PathogenAntifungal AgentsFungal InfectionsRespiratory InfectionInfectious Respiratory DiseaseInfection ControlMedicineClinical MicrobiologyAntimicrobial ResistanceHeart TransplantationAmphotericin B Prophylaxis